Prenatal Testing and Newborn Screening Market Share to Reach USD 10.85 Billion by 2027 | Emerging research

Emerging research logo

Rising prevalence of chromosomal syndrome in babies is one of the significant factors influencing the growth of the market.

VANCOUVER, BC, CANADA, June 8, 2022 / — Emergen Research recently published a new report on the Global Prenatal Screening and Newborn Screening Market which offers key insights regarding the regional and global scope of the Prenatal Testing and Newborn Screening market. It offers key details on recent product launches, technological advancements, supply-demand ratio and regulatory framework. The report also provides details about market size, market share, revenue growth and CAGR over the forecast period 2020-2027. The report also offers key insights on the top companies in the market along with in-depth SWOT analysis, Porter’s Five Forces analysis, and feasibility analysis to provide a competitive edge to readers. The report focuses on recent trends, key challenges and opportunities, and limitations relating to the ongoing pandemic.

The prenatal testing and newborn screening market is expected to reach $10.85 billion by 2027. Prenatal screening is considered superior to other screening modalities, especially for Down syndrome (one of the most common birth defects). widespread). Prenatal testing allows individuals to make informed decisions about whether diagnostic tests should be performed. Associated fetal chromosomal abnormalities usually include the benefit or absence of genetic material which may differ from small segments to small segments of chromosomes to whole chromosomes.

You can download a free sample PDF copy of this report at

Report Highlights

In April 2019, Progenity Inc. made an announcement regarding the introduction of the Resura Prenatal Test, a non-invasive, personalized prenatal check for monogenetic diseases.

Ultrasound should observe a significant growth rate during the forecast period, due to the ability of ultrasound diagnostics to detect abnormalities in the position of the baby and actions in the uterus.

The hospital held a substantial market share in 2019 due to the increasing introduction of non-invasive prenatal tests coupled with rapid technological developments in newborn screening, presence of skilled professionals and better reimbursement scenario.

North America dominated the prenatal testing and newborn screening market in 2019 owing to the availability of a state-of-the-art healthcare research system and developments in whole genome sequencing.

The report also discusses key players involved in the market such as Abbott Laboratories, Bio-Rad Laboratories, Color Genomics, Edinburgh Genomics, Eurofins Scientific, Agilent Technologies, CRISPR, Illumina Inc., Editas Medicine, and Qiagen NV, among others. and others as well as new market entrants. It focuses on recent mergers and acquisitions, joint ventures, collaborations, partnerships, licensing agreements, brand promotions and product launches, among others. The report also provides details about the company overview, business expansion plans, product portfolio, manufacturing and production capacity, global market position, financial condition and business base. consumers.

Main information presented in the report:

Market revenue share by major business players, by Type, by Application, and market scope of the global Prenatal Testing and Newborn Screening Market

Turnover of the main players and new entrants

Competitive analysis of key players including aspects such as company overview, product or service specifications, suppliers and buyers.

Recent mergers, acquisitions, product launches, recent investments and joint ventures

Regional analysis to provide insight into recent trends and opportunities

The competitive analysis also includes a regional analysis of major geographic regions. The report covers regions such as North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. The report also offers country-wise analysis to better understand the global Prenatal Testing and Newborn Screening market with respect to market share, market size, production and consumption ratio, product launches and activities. of R&D, investment opportunities and the presence of key players in the region.

To learn more about the report @

The report further segments the global Prenatal Screening & Newborn Screening market on the basis of product types and applications and provides insights into key factors influencing revenue growth of the segments.

Emergen Research has segmented the global prenatal testing and newborn screening market on the basis of type, type of test, technology, instrument, end-users, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)

Prenatal test

Newborn screening

Test Type Outlook (Revenue, USD Billion; 2017-2027)

Non invasive


Technology Outlook (Revenue, USD Billion; 2017-2027)

Mass spectrometry


Enzyme immunoassays

DNA analyzes

Instrument Outlook (Revenue, USD Billion; 2017-2027)


Reagent and assay kits

Tandem Quadrupole Detector

Shaker Incubator

Hearing screen instruments

End User Outlook (Revenue, USD Billion; 2017-2027)


Maternity and specialty clinics

Diagnostic centers

The report focuses on current and future market growth, technological advancements, volume, raw materials, and profiles of key companies involved in the market. The report provides valuable information for stakeholders, investors, product managers, marketing executives, and other industry professionals.

Request report customization @

Thank you for reading our report. Please contact us if you have any questions regarding the report or its customization. Our team will ensure that the report is best suited to your needs.

Browse our best press release–heart-rhythm-devices-market

Eric Lee
Emerging research
write to us here
Visit us on social media:

Prenatal Testing and Newborn Screening Market Size

Comments are closed.